Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma

Saved in:
Bibliographic Details
Published in:Blood advances 2024-01, Vol.8 (1), p.219-223
Main Authors: Paiva, Bruno, Zherniakova, Anastasiia, Nuñez-Córdoba, Jorge M, Rodriguez-Otero, Paula, Shi, Qian, Munshi, Nikhil C, Durie, Brian G M, San-Miguel, Jesus
Format: Article
Language:English
Subjects:
Disease-Free Survival
Humans
Multiple Myeloma - drug therapy
Randomized Controlled Trials as Topic
Research Letter
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c371t-24b5fb4c625a03f0b1cbcf06c6c89098883a4b51423f63e40e5451324b4008c83
cites cdi_FETCH-LOGICAL-c371t-24b5fb4c625a03f0b1cbcf06c6c89098883a4b51423f63e40e5451324b4008c83
container_end_page 223
container_issue 1
container_start_page 219
container_title Blood advances
container_volume 8
creator Paiva, Bruno
Zherniakova, Anastasiia
Nuñez-Córdoba, Jorge M
Rodriguez-Otero, Paula
Shi, Qian
Munshi, Nikhil C
Durie, Brian G M
San-Miguel, Jesus
description
doi_str_mv 10.1182/bloodadvances.2023010821
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10805640</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2858991632</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-24b5fb4c625a03f0b1cbcf06c6c89098883a4b51423f63e40e5451324b4008c83</originalsourceid><addsrcrecordid>eNpVUctuFDEQtBCIRCG_gHzksqFtz8x6uCAUCIkUBOJxtno87cXIHi-2N9Ly9ThKspBTl7qrqu0uxriAMyG0fD2FlGacb3CxVM4kSAUCtBRP2LHs1mo19mr99IDleMROS_kFAGI9qH6Uz9mRamhUUh6z_VXcoq08OV4zYY20VE7O0W1v4Z--vue4zPzLxbc3DXDcbDJtsBKfsWLrYNgXX7jLKfLcmCn6PzRzG_ziLYZm6jEU7hced6H6bSAe9xRSxBfsmWsjOr2vJ-zHxYfv55er688fr87fXa-sWou6kt3Uu6mzg-wRlINJ2Mk6GOxg9Qij1lpho4hOKjco6oD6rheqyToAbbU6YW_vfLe7KdJs2wczBrPNPmLem4TePJ4s_qfZpBvTjgr90EFzeHXvkNPvHZVqoi-WQsCF0q4YqXs9jmJQslH1HdXmVEomd9gjwNymZx6lZ_6l16Qv_3_nQfiQlfoLtzKbWQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2858991632</pqid></control><display><type>article</type><title>Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma</title><source>ScienceDirect</source><source>PubMed Central Free</source><creator>Paiva, Bruno ; Zherniakova, Anastasiia ; Nuñez-Córdoba, Jorge M ; Rodriguez-Otero, Paula ; Shi, Qian ; Munshi, Nikhil C ; Durie, Brian G M ; San-Miguel, Jesus</creator><creatorcontrib>Paiva, Bruno ; Zherniakova, Anastasiia ; Nuñez-Córdoba, Jorge M ; Rodriguez-Otero, Paula ; Shi, Qian ; Munshi, Nikhil C ; Durie, Brian G M ; San-Miguel, Jesus</creatorcontrib><identifier>ISSN: 2473-9529</identifier><identifier>ISSN: 2473-9537</identifier><identifier>EISSN: 2473-9537</identifier><identifier>DOI: 10.1182/bloodadvances.2023010821</identifier><identifier>PMID: 37639322</identifier><language>eng</language><publisher>United States: The American Society of Hematology</publisher><subject>Disease-Free Survival ; Humans ; Multiple Myeloma - drug therapy ; Randomized Controlled Trials as Topic ; Research Letter ; Treatment Outcome</subject><ispartof>Blood advances, 2024-01, Vol.8 (1), p.219-223</ispartof><rights>2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2024 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-24b5fb4c625a03f0b1cbcf06c6c89098883a4b51423f63e40e5451324b4008c83</citedby><cites>FETCH-LOGICAL-c371t-24b5fb4c625a03f0b1cbcf06c6c89098883a4b51423f63e40e5451324b4008c83</cites><orcidid>0000-0003-1977-3815 ; 0000-0001-5236-7785 ; 0000-0002-9183-4857</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10805640/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10805640/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37639322$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paiva, Bruno</creatorcontrib><creatorcontrib>Zherniakova, Anastasiia</creatorcontrib><creatorcontrib>Nuñez-Córdoba, Jorge M</creatorcontrib><creatorcontrib>Rodriguez-Otero, Paula</creatorcontrib><creatorcontrib>Shi, Qian</creatorcontrib><creatorcontrib>Munshi, Nikhil C</creatorcontrib><creatorcontrib>Durie, Brian G M</creatorcontrib><creatorcontrib>San-Miguel, Jesus</creatorcontrib><title>Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma</title><title>Blood advances</title><addtitle>Blood Adv</addtitle><subject>Disease-Free Survival</subject><subject>Humans</subject><subject>Multiple Myeloma - drug therapy</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Research Letter</subject><subject>Treatment Outcome</subject><issn>2473-9529</issn><issn>2473-9537</issn><issn>2473-9537</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVUctuFDEQtBCIRCG_gHzksqFtz8x6uCAUCIkUBOJxtno87cXIHi-2N9Ly9ThKspBTl7qrqu0uxriAMyG0fD2FlGacb3CxVM4kSAUCtBRP2LHs1mo19mr99IDleMROS_kFAGI9qH6Uz9mRamhUUh6z_VXcoq08OV4zYY20VE7O0W1v4Z--vue4zPzLxbc3DXDcbDJtsBKfsWLrYNgXX7jLKfLcmCn6PzRzG_ziLYZm6jEU7hced6H6bSAe9xRSxBfsmWsjOr2vJ-zHxYfv55er688fr87fXa-sWou6kt3Uu6mzg-wRlINJ2Mk6GOxg9Qij1lpho4hOKjco6oD6rheqyToAbbU6YW_vfLe7KdJs2wczBrPNPmLem4TePJ4s_qfZpBvTjgr90EFzeHXvkNPvHZVqoi-WQsCF0q4YqXs9jmJQslH1HdXmVEomd9gjwNymZx6lZ_6l16Qv_3_nQfiQlfoLtzKbWQ</recordid><startdate>20240109</startdate><enddate>20240109</enddate><creator>Paiva, Bruno</creator><creator>Zherniakova, Anastasiia</creator><creator>Nuñez-Córdoba, Jorge M</creator><creator>Rodriguez-Otero, Paula</creator><creator>Shi, Qian</creator><creator>Munshi, Nikhil C</creator><creator>Durie, Brian G M</creator><creator>San-Miguel, Jesus</creator><general>The American Society of Hematology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1977-3815</orcidid><orcidid>https://orcid.org/0000-0001-5236-7785</orcidid><orcidid>https://orcid.org/0000-0002-9183-4857</orcidid></search><sort><creationdate>20240109</creationdate><title>Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma</title><author>Paiva, Bruno ; Zherniakova, Anastasiia ; Nuñez-Córdoba, Jorge M ; Rodriguez-Otero, Paula ; Shi, Qian ; Munshi, Nikhil C ; Durie, Brian G M ; San-Miguel, Jesus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-24b5fb4c625a03f0b1cbcf06c6c89098883a4b51423f63e40e5451324b4008c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Disease-Free Survival</topic><topic>Humans</topic><topic>Multiple Myeloma - drug therapy</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Research Letter</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paiva, Bruno</creatorcontrib><creatorcontrib>Zherniakova, Anastasiia</creatorcontrib><creatorcontrib>Nuñez-Córdoba, Jorge M</creatorcontrib><creatorcontrib>Rodriguez-Otero, Paula</creatorcontrib><creatorcontrib>Shi, Qian</creatorcontrib><creatorcontrib>Munshi, Nikhil C</creatorcontrib><creatorcontrib>Durie, Brian G M</creatorcontrib><creatorcontrib>San-Miguel, Jesus</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paiva, Bruno</au><au>Zherniakova, Anastasiia</au><au>Nuñez-Córdoba, Jorge M</au><au>Rodriguez-Otero, Paula</au><au>Shi, Qian</au><au>Munshi, Nikhil C</au><au>Durie, Brian G M</au><au>San-Miguel, Jesus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma</atitle><jtitle>Blood advances</jtitle><addtitle>Blood Adv</addtitle><date>2024-01-09</date><risdate>2024</risdate><volume>8</volume><issue>1</issue><spage>219</spage><epage>223</epage><pages>219-223</pages><issn>2473-9529</issn><issn>2473-9537</issn><eissn>2473-9537</eissn><cop>United States</cop><pub>The American Society of Hematology</pub><pmid>37639322</pmid><doi>10.1182/bloodadvances.2023010821</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-1977-3815</orcidid><orcidid>https://orcid.org/0000-0001-5236-7785</orcidid><orcidid>https://orcid.org/0000-0002-9183-4857</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2473-9529
ispartof Blood advances, 2024-01, Vol.8 (1), p.219-223
issn 2473-9529
2473-9537
2473-9537
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10805640
source ScienceDirect; PubMed Central Free
subjects Disease-Free Survival
Humans
Multiple Myeloma - drug therapy
Randomized Controlled Trials as Topic
Research Letter
Treatment Outcome
title Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T19%3A48%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20treatment%20effect%20on%20MRD%20and%20PFS:%20an%20aggregate%20data%20analysis%20from%20randomized%20clinical%20trials%20in%20multiple%20myeloma&rft.jtitle=Blood%20advances&rft.au=Paiva,%20Bruno&rft.date=2024-01-09&rft.volume=8&rft.issue=1&rft.spage=219&rft.epage=223&rft.pages=219-223&rft.issn=2473-9529&rft.eissn=2473-9537&rft_id=info:doi/10.1182/bloodadvances.2023010821&rft_dat=%3Cproquest_pubme%3E2858991632%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c371t-24b5fb4c625a03f0b1cbcf06c6c89098883a4b51423f63e40e5451324b4008c83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2858991632&rft_id=info:pmid/37639322&rfr_iscdi=true